New drug - Volibris
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
OPINION
EMMA BOWER
Opinions
Extended hours work must be fairly paid
by Emma Bower
04-Aug-08 00:00
Although the final extended hours directed enhanced service (DES) has yet to be published, the DoH h... Read more
Ministers must not rush on polyclinics
by Emma Bower
16-Jun-08 00:00
Polyclinics are either the panacea to the NHS's ills or a threat to the very future of primary care,... Read more
Social services funding debate is long overdue
by Emma Bower
19-May-08 00:00
Last week the government announced it is to hold a six-month debate on the future of care and suppor... Read more
A standing ovation for the health secretary
by Emma Bower
05-May-08 00:00
What a difference two years can make. In 2006, the then health secretary Patricia Hewitt was forced ... Read more
Nurses deserve better training opportunities
by Emma Bower
07-Apr-08 00:00
Last month it was announced that one of the final barriers to nurse prescribing is to be scrapped (I... Read more
The DoH must keep up with nursing changes
by Emma Bower
17-Mar-08 00:00
Recent years have seen huge changes in the way many NHS services are delivered, but it seems that th... Read more
Change is needed to ensure nurse-led care
by Emma Bower
03-Mar-08 00:00
The DoH set out its vision of an expanded role for primary care nurses in 2002's Liberating the Tale... Read more
Extended hours plans will impact on nurses
by Emma Bower
18-Feb-08 00:00
At the time of writing it seems that GPs will vote to accept the revised extended hours directed enh... Read more
Your chance to shape the future of nursing
by Emma Bower
04-Feb-08 00:00
During the next fortnight the consultations on the future of pre- and post-registration education wi... Read more
Community pilots could spell disaster
by Emma Bower
21-Jan-08 00:00
News that the Scottish government is pushing ahead with plans to reform community nursing has caused... Read more
Healthcare Republic Forums
Hottest Topics
MIMS Product News
New drug - Thymoglobuline
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
New drug - Tyverb
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Jobs
Job of the Week
- Practice Manager South West England
- Part-time Practice Manager Central London
- Business Manager South East England
- Practice Manager East Midlands
- Practice Manager East London
